New Alzheimers drugs may lower damage caused by traumatic brain injuryMarch 16th, 2009 - 12:12 pm ICT by ANI
London, Mar 16 (ANI): A new class of Alzheimers drugs have been found to reduce long-term damage caused by traumatic brain injury, say researchers from Georgetown University Medical Centre.
The drugs called gamma-secretase inhibitors are designed to target amyloid plaque that accumulates in the brains of people with Alzheimer’’s disease.
“No one knows why it occurs, but abnormal amounts of amyloid plaque have been found during an autopsy in about a third of brain injury victims, some of whom were children who would ordinarily never have had these deposits,” Nature magazine quoted Dr. Mark Burns, an assistant professor at GUMC, as saying.
“Remarkably, these deposits may occur in less than one day after injury,” he added.
The researchers found that the same pathways activated chronically in Alzheimer’’s disease are activated acutely in traumatic brain injury, and that they appeared to play a very important role in secondary injury.
Moreover, people who suffered a brain injury were at a 400 percent increased risk of developing the disorder.
During the study, the researchers sought to understand whether amyloid peptide contributed to secondary injury. They used two different approaches to blocking activation of the pathway that produces amyloid peptide.
The mice used in the study were genetically altered to lack beta secretase, which meant they were incapable of producing amyloid.
The researchers also treated “normal” mice with the experimental agent DAPT, one of the first gamma secretase inhibitors currently undergoing trails.
As a result, amyloid peptide production was substantially reduced in that group.
They found that in normal control mice, brain injury produced substantially more amyloid peptide, and that the brain region known as the hippocampus, which is also affected in Alzheimer’’s disease, was substantially damaged.
They then followed the groups of reduced amyloid mice after injury, and found that three weeks after initial trauma, both groups performed almost equally well on learning tests.
“The experiment with the genetically altered mice shows that amyloid peptide contributes to the secondary damage seen in traumatic brain injury,” he said.
“If injured mice that cannot develop amyloid demonstrate reduced signs of secondary trauma, that points to amyloid peptide as a cause of this continuing damage,” he added.
The findings appear in the journal Nature Medicine. (ANI)
- Asthma drug could help fight Alzheimer's disease - Mar 26, 2011
- Alzheimer's disease drug may treat traumatic brain injury too - Jul 13, 2009
- Asthma drug could help fight Alzheimer's - Mar 27, 2011
- Alzheimer's drug not as harmful as believed - Jun 18, 2010
- Scientists eliminate plaque formation in Alzheimer's - Sep 06, 2012
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
- Sleep disorders are early signs of Alzheimer's - Sep 06, 2012
- Liver, not brain, may be source of Alzheimer's plaques - Mar 04, 2011
- Drug reverses Alzheimer's symptoms in mice: Study - Feb 10, 2012
- Novel gene therapy shows promise against Alzheimer's - Mar 05, 2011
- Rheumatoid arthritis may protect against Alzheimer's disease - Aug 23, 2010
- New drugs for Alzheimer's may also treat traumatic brain injury - Jul 13, 2009
- New method to cleanse brain of Alzheimer's plaques developed - Dec 10, 2010
- Proteins responsible for Alzheimer's 'may spread through infection' - Oct 22, 2010
- Chronic high cholesterol diet leads to brain damage: Study - Nov 25, 2010
Tags: abnormal amounts, assistant professor, autopsy, brain injury victims, brain region, brains, control mice, dr mark, drugs, georgetown university medical, gumc, hippocampus, mark burns, nature magazine, pathway, pathways, peptide, plaque, traumatic brain injury, university medical centre